Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 112 Pages
Report ld: 3499400
Request Sample
Customized Report
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
With the continuous advancement of medical technology, prefilled syringes have been playing an increasingly vital role in the field of pharmaceutical delivery. Enoxaparin sodium, a commonly used anticoagulant medication, is now being offered in the form of prefilled syringes known as Enoxaparin Sodium Prefilled Syringes. This innovative delivery method is gradually becoming the preferred choice for anticoagulant therapy, driven by its convenience and precise dosing capabilities. The Enoxaparin Sodium Prefilled Syringes not only reduce the complexity for healthcare providers but also offer patients a more comfortable and convenient medication experience. As the aging population grows and anticoagulant treatments continue to see widespread adoption, the market for Enoxaparin Sodium Prefilled Syringes is poised for sustained growth.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium Prefilled Syringes, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enoxaparin Sodium Prefilled Syringes by region & country, by Type, and by Application.
The Enoxaparin Sodium Prefilled Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium Prefilled Syringes.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enoxaparin Sodium Prefilled Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Enoxaparin Sodium Prefilled Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Enoxaparin Sodium Prefilled Syringes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Enoxaparin Sodium Prefilled Syringes Product Introduction
1.2 Global Enoxaparin Sodium Prefilled Syringes Market Size Forecast
1.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Value (2020-2031)
1.2.2 Global Enoxaparin Sodium Prefilled Syringes Sales Volume (2020-2031)
1.2.3 Global Enoxaparin Sodium Prefilled Syringes Sales Price (2020-2031)
1.3 Enoxaparin Sodium Prefilled Syringes Market Trends & Drivers
1.3.1 Enoxaparin Sodium Prefilled Syringes Industry Trends
1.3.2 Enoxaparin Sodium Prefilled Syringes Market Drivers & Opportunity
1.3.3 Enoxaparin Sodium Prefilled Syringes Market Challenges
1.3.4 Enoxaparin Sodium Prefilled Syringes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enoxaparin Sodium Prefilled Syringes Players Revenue Ranking (2024)
2.2 Global Enoxaparin Sodium Prefilled Syringes Revenue by Company (2020-2025)
2.3 Global Enoxaparin Sodium Prefilled Syringes Players Sales Volume Ranking (2024)
2.4 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Company Players (2020-2025)
2.5 Global Enoxaparin Sodium Prefilled Syringes Average Price by Company (2020-2025)
2.6 Key Manufacturers Enoxaparin Sodium Prefilled Syringes Manufacturing Base and Headquarters
2.7 Key Manufacturers Enoxaparin Sodium Prefilled Syringes Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Enoxaparin Sodium Prefilled Syringes
2.9 Enoxaparin Sodium Prefilled Syringes Market Competitive Analysis
2.9.1 Enoxaparin Sodium Prefilled Syringes Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Enoxaparin Sodium Prefilled Syringes Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium Prefilled Syringes as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 20 mg/0.2mL
3.1.2 30 mg/0.3mL
3.1.3 40 mg/0.4mL
3.1.4 60 mg/0.6mL
3.1.5 80 mg/0.8mL
3.1.6 100 mg/1mL
3.1.7 120 mg/0.8mL
3.1.8 150 mg/1mL
3.2 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Type
3.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Enoxaparin Sodium Prefilled Syringes Sales Value, by Type (2020-2031)
3.2.3 Global Enoxaparin Sodium Prefilled Syringes Sales Value, by Type (%) (2020-2031)
3.3 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Type
3.3.1 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Enoxaparin Sodium Prefilled Syringes Sales Volume, by Type (2020-2031)
3.3.3 Global Enoxaparin Sodium Prefilled Syringes Sales Volume, by Type (%) (2020-2031)
3.4 Global Enoxaparin Sodium Prefilled Syringes Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Application
4.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Enoxaparin Sodium Prefilled Syringes Sales Value, by Application (2020-2031)
4.2.3 Global Enoxaparin Sodium Prefilled Syringes Sales Value, by Application (%) (2020-2031)
4.3 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Application
4.3.1 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Enoxaparin Sodium Prefilled Syringes Sales Volume, by Application (2020-2031)
4.3.3 Global Enoxaparin Sodium Prefilled Syringes Sales Volume, by Application (%) (2020-2031)
4.4 Global Enoxaparin Sodium Prefilled Syringes Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Region
5.1.1 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Region (2020-2025)
5.1.3 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Region (2026-2031)
5.1.4 Global Enoxaparin Sodium Prefilled Syringes Sales Value by Region (%), (2020-2031)
5.2 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Region
5.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Region (2020-2025)
5.2.3 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Region (2026-2031)
5.2.4 Global Enoxaparin Sodium Prefilled Syringes Sales Volume by Region (%), (2020-2031)
5.3 Global Enoxaparin Sodium Prefilled Syringes Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
5.4.2 North America Enoxaparin Sodium Prefilled Syringes Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
5.5.2 Europe Enoxaparin Sodium Prefilled Syringes Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
5.6.2 Asia Pacific Enoxaparin Sodium Prefilled Syringes Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
5.7.2 South America Enoxaparin Sodium Prefilled Syringes Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
5.8.2 Middle East & Africa Enoxaparin Sodium Prefilled Syringes Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enoxaparin Sodium Prefilled Syringes Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Enoxaparin Sodium Prefilled Syringes Sales Value
6.2.1 Key Countries/Regions Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.2.2 Key Countries/Regions Enoxaparin Sodium Prefilled Syringes Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.3.2 United States Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.4.2 Europe Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.5.2 China Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.5.3 China Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.6.2 Japan Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.7.2 South Korea Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.8.2 Southeast Asia Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Enoxaparin Sodium Prefilled Syringes Sales Value, 2020-2031
6.9.2 India Enoxaparin Sodium Prefilled Syringes Sales Value by Type (%), 2024 VS 2031
6.9.3 India Enoxaparin Sodium Prefilled Syringes Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Sanofi Enoxaparin Sodium Prefilled Syringes Product Offerings
7.1.5 Sanofi Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Introduction and Business Overview
7.2.3 Teva Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Teva Enoxaparin Sodium Prefilled Syringes Product Offerings
7.2.5 Teva Recent Development
7.3 Rovi
7.3.1 Rovi Company Information
7.3.2 Rovi Introduction and Business Overview
7.3.3 Rovi Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Rovi Enoxaparin Sodium Prefilled Syringes Product Offerings
7.3.5 Rovi Recent Development
7.4 Amphastar
7.4.1 Amphastar Company Information
7.4.2 Amphastar Introduction and Business Overview
7.4.3 Amphastar Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Amphastar Enoxaparin Sodium Prefilled Syringes Product Offerings
7.4.5 Amphastar Recent Development
7.5 Techdow (Hepalink)
7.5.1 Techdow (Hepalink) Company Information
7.5.2 Techdow (Hepalink) Introduction and Business Overview
7.5.3 Techdow (Hepalink) Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Techdow (Hepalink) Enoxaparin Sodium Prefilled Syringes Product Offerings
7.5.5 Techdow (Hepalink) Recent Development
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Information
7.6.2 Fresenius Kabi Introduction and Business Overview
7.6.3 Fresenius Kabi Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Fresenius Kabi Enoxaparin Sodium Prefilled Syringes Product Offerings
7.6.5 Fresenius Kabi Recent Development
7.7 Nanjing King-friend
7.7.1 Nanjing King-friend Company Information
7.7.2 Nanjing King-friend Introduction and Business Overview
7.7.3 Nanjing King-friend Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Nanjing King-friend Enoxaparin Sodium Prefilled Syringes Product Offerings
7.7.5 Nanjing King-friend Recent Development
7.8 Sandoz
7.8.1 Sandoz Company Information
7.8.2 Sandoz Introduction and Business Overview
7.8.3 Sandoz Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sandoz Enoxaparin Sodium Prefilled Syringes Product Offerings
7.8.5 Sandoz Recent Development
7.9 Apotex
7.9.1 Apotex Company Information
7.9.2 Apotex Introduction and Business Overview
7.9.3 Apotex Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Apotex Enoxaparin Sodium Prefilled Syringes Product Offerings
7.9.5 Apotex Recent Development
7.10 Hangzhou Jiuyuan Gene Engineering
7.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
7.10.2 Hangzhou Jiuyuan Gene Engineering Introduction and Business Overview
7.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Prefilled Syringes Product Offerings
7.10.5 Hangzhou Jiuyuan Gene Engineering Recent Development
7.11 Cipla
7.11.1 Cipla Company Information
7.11.2 Cipla Introduction and Business Overview
7.11.3 Cipla Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Cipla Enoxaparin Sodium Prefilled Syringes Product Offerings
7.11.5 Cipla Recent Development
7.12 Taj Pharma
7.12.1 Taj Pharma Company Information
7.12.2 Taj Pharma Introduction and Business Overview
7.12.3 Taj Pharma Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Taj Pharma Enoxaparin Sodium Prefilled Syringes Product Offerings
7.12.5 Taj Pharma Recent Development
7.13 Chengdu Baiyu Pharmaceutical
7.13.1 Chengdu Baiyu Pharmaceutical Company Information
7.13.2 Chengdu Baiyu Pharmaceutical Introduction and Business Overview
7.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Prefilled Syringes Product Offerings
7.13.5 Chengdu Baiyu Pharmaceutical Recent Development
7.14 Changzhou Qianhong Bio-pharma
7.14.1 Changzhou Qianhong Bio-pharma Company Information
7.14.2 Changzhou Qianhong Bio-pharma Introduction and Business Overview
7.14.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Prefilled Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Prefilled Syringes Product Offerings
7.14.5 Changzhou Qianhong Bio-pharma Recent Development
8 Industry Chain Analysis
8.1 Enoxaparin Sodium Prefilled Syringes Industrial Chain
8.2 Enoxaparin Sodium Prefilled Syringes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Enoxaparin Sodium Prefilled Syringes Sales Model
8.5.2 Sales Channel
8.5.3 Enoxaparin Sodium Prefilled Syringes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
The global Enoxaparin Sodium Prefilled Syringes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
The global Enoxaparin Sodium Prefilled Syringes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 95
USD 4250.00
(Single User License)
The global Enoxaparin Sodium Prefilled Syringes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Enoxaparin Sodium Prefilled Syringes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 88
USD 2900.00
(Single User License)
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
The global Enoxaparin Sodium Prefilled Syringes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 118
The global Enoxaparin Sodium Prefilled Syringes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
The global Enoxaparin Sodium Prefilled Syringes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Enoxaparin Sodium Prefilled Syringes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 88
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
Published: 2024-01-17
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now